NO934293L - Fremgangsmåte og streptomycesstamme for fremstilling av antiparastiske forbindelser - Google Patents

Fremgangsmåte og streptomycesstamme for fremstilling av antiparastiske forbindelser

Info

Publication number
NO934293L
NO934293L NO934293A NO934293A NO934293L NO 934293 L NO934293 L NO 934293L NO 934293 A NO934293 A NO 934293A NO 934293 A NO934293 A NO 934293A NO 934293 L NO934293 L NO 934293L
Authority
NO
Norway
Prior art keywords
antiparastic
compounds
preparation
streptomyces strain
microorganism
Prior art date
Application number
NO934293A
Other languages
English (en)
Norwegian (no)
Other versions
NO934293D0 (no
Inventor
Rosanne Bonjouklian
Jr Otis Webster Godfrey
Tim Allen Smitka
Raymond Che-Fong Yao
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO934293D0 publication Critical patent/NO934293D0/no
Publication of NO934293L publication Critical patent/NO934293L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
    • C12P19/623—Avermectin; Milbemycin; Ivermectin; C-076
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/188—Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
NO934293A 1992-11-30 1993-11-26 Fremgangsmåte og streptomycesstamme for fremstilling av antiparastiske forbindelser NO934293L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/984,078 US5292647A (en) 1992-11-30 1992-11-30 Strain of streptomyces for producing avermectins and processes therewith

Publications (2)

Publication Number Publication Date
NO934293D0 NO934293D0 (no) 1993-11-26
NO934293L true NO934293L (no) 1994-05-31

Family

ID=25530287

Family Applications (1)

Application Number Title Priority Date Filing Date
NO934293A NO934293L (no) 1992-11-30 1993-11-26 Fremgangsmåte og streptomycesstamme for fremstilling av antiparastiske forbindelser

Country Status (21)

Country Link
US (1) US5292647A (de)
EP (1) EP0600656A3 (de)
JP (1) JPH06237761A (de)
KR (1) KR940011630A (de)
CN (1) CN1088983A (de)
AU (1) AU667141B2 (de)
BR (1) BR9304843A (de)
CA (1) CA2109767A1 (de)
CO (1) CO4130314A1 (de)
CZ (1) CZ282908B6 (de)
FI (1) FI935246A7 (de)
HU (1) HUT69970A (de)
IL (1) IL107702A (de)
MX (1) MX9307410A (de)
MY (1) MY109797A (de)
NO (1) NO934293L (de)
NZ (1) NZ250247A (de)
PH (1) PH30116A (de)
PL (1) PL301204A1 (de)
RU (1) RU2125609C1 (de)
ZA (1) ZA938723B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6197591B1 (en) * 1998-09-14 2001-03-06 Pfizer Inc. Streptomyces avermitilis regulatory genes for increased avermectin production
RU2147320C1 (ru) * 1999-09-22 2000-04-10 Автономная Некоммерческая Организация "Научно-Исследовательский Центр Биотехнологии Антибиотиков И Других Биологически Активных Веществ "Биоан" Штамм streptomyces avermitilis ницб 132-продуцент авермектинов
KR100419554B1 (ko) * 1999-10-29 2004-02-19 주식회사유한양행 아버멕틴의 정제방법
RU2182174C2 (ru) * 2000-01-31 2002-05-10 Мосин Владимир Александрович Способ выделения авермектиновых комплексов
GB2426621B (en) * 2004-01-08 2008-05-21 Sharp Kk Lighting device for display devices, liquid crystal display device, and light source lamp
CN100448984C (zh) * 2006-03-07 2009-01-07 广东省微生物研究所 粤蓝链霉菌
RU2391396C2 (ru) * 2007-04-27 2010-06-10 Государственное учреждение научно-исследовательский институт по изысканию новых антибиотиков им. Г.Ф. Гаузе РАМН (ГУ НИИНА им. Г.Ф.Гаузе РАМН) ШТАММ Streptomyces roseolus ВКПМ S-1082 - ПРОДУЦЕНТ ЛИНКОМИЦИНА И СПОСОБ ПОЛУЧЕНИЯ ЛИНКОМИЦИНА
CN102016054A (zh) * 2008-04-25 2011-04-13 株式会社太平洋 用生物转化系统制备正二羟基异黄酮的方法
CN102443555B (zh) * 2011-11-16 2013-04-24 南开大学 链霉菌Streptomyces sp.NK-660及其用于生产ε-聚赖氨酸的发酵培养方法
KR101833984B1 (ko) * 2015-09-22 2018-03-02 주식회사 팜한농 밀베마이신을 생산하는 재조합 미생물 및 이를 이용한 밀베마이신 생산 방법
KR102017788B1 (ko) * 2017-09-18 2019-09-03 주식회사 팜한농 밀베마이신 d를 생산하는 재조합 미생물 및 밀베마이신 d 생산 방법
CN114075527B (zh) * 2021-10-25 2024-03-26 成都大学 一种脂溶性抗生素生物发酵调控的方法
CN116478865A (zh) * 2023-03-22 2023-07-25 河北兴柏农业科技股份有限公司 一种增产阿维菌素的发酵培养基及发酵方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE434277B (sv) * 1976-04-19 1984-07-16 Merck & Co Inc Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis
US4199569A (en) * 1977-10-03 1980-04-22 Merck & Co., Inc. Selective hydrogenation products of C-076 compounds and derivatives thereof
US4429042A (en) * 1978-09-08 1984-01-31 Merck & Co., Inc. Strain of Streptomyces for producing antiparasitic compounds
US4378353A (en) * 1981-02-17 1983-03-29 Merck & Co., Inc. Novel C-076 compounds
ES8800986A1 (es) * 1985-07-27 1987-12-01 Pfizer Un procedimiento para la produccion de un nuevo derivado de avermectina
IN167980B (de) * 1987-01-23 1991-01-19 Pfizer
EP0284176B1 (de) * 1987-01-23 1993-08-25 Pfizer Inc. Verfahren zur Herstellung von Avermectinen und die verwendeten Kulturen
US5015662A (en) * 1988-10-18 1991-05-14 Merck & Co., Inc. Anthelmintic bioconversion products
JP2888586B2 (ja) * 1990-03-05 1999-05-10 社団法人北里研究所 エバーメクチンの特定成分を選択生産するための微生物およびその選択的製造法

Also Published As

Publication number Publication date
CO4130314A1 (es) 1995-02-13
CA2109767A1 (en) 1994-05-31
FI935246L (fi) 1994-05-31
CN1088983A (zh) 1994-07-06
HUT69970A (en) 1995-09-28
NO934293D0 (no) 1993-11-26
MX9307410A (es) 1994-07-29
IL107702A0 (en) 1994-02-27
IL107702A (en) 1998-10-30
AU5196093A (en) 1994-06-09
ZA938723B (en) 1995-05-22
JPH06237761A (ja) 1994-08-30
AU667141B2 (en) 1996-03-07
FI935246A7 (fi) 1994-05-31
EP0600656A2 (de) 1994-06-08
MY109797A (en) 1997-07-31
BR9304843A (pt) 1994-06-14
HU9303366D0 (en) 1994-03-28
US5292647A (en) 1994-03-08
EP0600656A3 (de) 1995-07-05
KR940011630A (ko) 1994-06-21
CZ250293A3 (en) 1994-06-15
FI935246A0 (fi) 1993-11-25
CZ282908B6 (cs) 1997-11-12
PL301204A1 (en) 1994-06-13
PH30116A (en) 1996-12-27
RU2125609C1 (ru) 1999-01-27
NZ250247A (en) 1994-12-22

Similar Documents

Publication Publication Date Title
BG44205A3 (en) Method for preparing of antibiotic s541
IE782421L (en) Pleuromutilin glycosides
GB9621771D0 (en) Method of treatment of heart disease
MY109797A (en) Strain of streptomyces for producing antiparasitic compounds and processes therewith.
AU578615B2 (en) Anthracycline derivatives, a microbiological process for their preparation and their use as cytostatics
RU93052142A (ru) Штамм стрептомицетов для продуцирования антипаразитарных соединений и способы продуцирования этих соединений
AU3784089A (en) Avermectin and milbemycin derivatives from streptomyces avermitiosis ATCC 31267, 31271 and 31272
IL81857A (en) Insecticidal compositions for controlling scarabid larvae,containing bacterial spored of milky disease bacillus free of sporangia,and in vitro method for producing such spores
NO163574C (no) Fremgangsmaate for fremstilling av antitumor-antibiotika (ll-e33288 kompleks) ved fermentering av micromonospora echinospora ssp. calichensis nrrl 1539 og nrrl 15975.
IE812616L (en) Macrolide antibiotic
AU1844688A (en) Novel 3',4'-dinitrogen substituted epipodophyllotoxin glucoside derivatives
AU644013B2 (en) Microbial preparation of 13beta-13-hydroxy-22,23-dihydro avermectin-Bla/Blb aglycone
ZA884653B (en) Antitumor agent obtained by microbial stereoselective reduction of 4'-deoxy-4'-iododoxorubicin
EP0325462A3 (de) Milbemycin-Derivate mit anthelmintischer Wirkung
ES8706816A1 (es) Un procedimiento para la preparacion de un nuevo compuesto denominado sustancia n. 51262 por cultivo de un microorganismo del genero streptomyces
EP0083019A3 (de) Verfahren zur Herstellung von aktiven Anthracyklinglykosiden, 4-deoxy-Aklacinomycin A und B, und deren pharmazeutische Zusammensetzungen
ES8400489A1 (es) Un metodo para la preparacion de 2-hidroxi-aclacinomicinas a, b y n.
GR74471B (de)
AU562464B2 (en) Macrolide ptl-448-a,b,c and d
EP0100075A3 (de) Verfahren zur Herstellung von Daunomycin
AU8298687A (en) Amycin and its derivatives, a process for their preparation, and their use
EP0454494A3 (en) Calicheamicinone, derivatives and analogs thereof and methods of making the same
NZ180300A (en) Antibiotic 32,999 rp produced by microbiological reduction and by cultivation of streptomyces coeruleorubidus(nrrl 3046,nrrl o045nrrl 8098)strepthomyces bifurcus(nrrl3539)andstreptomyces atroviolaceus(nrrl 8148)
AU3836593A (en) Active principle based on avermectins, related strain and process for the preparation thereof, as well as veterinary composition containing it
CS109090A2 (en) Strain of microorganism streptomyces sp., ccm 4102 that produces isomerase's intracellular glucose